Skip to content
healthcare.dev

Rufinamide

NDC 67877-673, Rufinamide, suspension, from Ascend Laboratories, LLC.

Product NDC
67877-673
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213410
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-673 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RUFINAMIDE40 mg/mL
Package NDCNDC-11Package
67877-673-62678770673621 BOTTLE in 1 CARTON (67877-673-62) / 460 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a02ca527-bd8f-49ef-89fa-91fac154bffe
  • NADAC price for package 67877067362

    GET /v1/drugs/nadac/67877067362

Use it

Look up 67877-673 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-673 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-673. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.